Schedule 4 Advertising Compliance: The 'Lip Flip' Trap and What Cosmetic Clinics Need to Audit Today

Most cosmetic clinics in Australia have a "lip flip" page. Or an "anti-wrinkle injections" page. Or a "dermal fillers" page. They are written carefully — no brand names, no exaggerated claims, treatment-focused copy. And many of them are still in breach of the Therapeutic Goods Advertising Code.

The reason is the indirect reference rule, and it is one of the most common — and most poorly understood — sources of AHPRA notifications in 2026. This article covers what's actually banned, why the seemingly safe descriptors don't pass the test, and how to audit your own treatment pages this week.

What does Schedule 4 mean for cosmetic advertising?

Botulinum toxin (Botox, Dysport, Xeomin), dermal fillers (Juvéderm, Restylane, Belotero, Teoxane), and other injectable cosmetic products are classified as Schedule 4 prescription-only medicines under the Therapeutic Goods Act 1989.

The Therapeutic Goods Advertising Code (2022) is unambiguous. Schedule 4 products cannot be advertised to the public, either directly or indirectly. This is not new — what's new is enforcement.

The "indirectly" qualifier is the part that catches clinics. The TGA and AHPRA have made clear that you cannot work around the brand-name prohibition by using treatment descriptors that point patients toward a specific Schedule 4 product. The published website compliance audit checklist names this directly:

Avoid using treatment category descriptors like 'anti-wrinkle injections', 'dermal fillers' or 'lip flip' if they are being used to indirectly refer to specific Schedule 4 products. Even indirect references may be considered a breach.

The indirect reference test: how to know if your page breaches

Apply this test to each treatment page on your website:

1. Is there a treatment descriptor that maps to a specific Schedule 4 product?

"Anti-wrinkle injections" maps to botulinum toxin. "Dermal fillers" maps to hyaluronic acid filler products. "Lip flip" is a procedure exclusively performed with botulinum toxin. "Profhilo" or "bio-stimulators" map to specific named products. "PRP" usually maps to a registered medical device or product.

2. Does the page imply a specific outcome that only a Schedule 4 product can produce?

If the page says "smoother skin", "fuller lips", "fewer fine lines", and the only way to produce that result is a Schedule 4 product, the page is implicitly advertising that product.

3. Does the page use imagery that depicts the result of a Schedule 4 product?

Before-and-after images of treated areas — lips, glabellar lines, nasolabial folds — are images of Schedule 4 product outcomes, even if no brand name appears.

4. Does the page contain hashtags, captions, or metadata referencing Schedule 4 products?

Hashtags like #botox or #juvederm on the page or in social posts that link to it count as references. Image alt-text and metadata are also indexed.

If any of those four are true, your page is at risk under the indirect reference rule.

What you can advertise (and how)

Cosmetic medical practices remain businesses, and there are compliant ways to communicate what you offer. The general principle is that you can advertise your practice and services in a generic, non-product-specific way, but you cannot promote specific Schedule 4 products or imply specific Schedule 4 outcomes.

Compliant approaches:

Practitioner credentials and scope of practice. "Our injectors are AHPRA-registered nurses with [specific qualifications]." This is about the practitioner, not the product.
Generic procedural information. "Treatments at our clinic begin with a consultation by a registered medical practitioner." Procedural without product specificity.
Educational content about conditions and concerns. Articles about ageing, facial volume changes, skin health — without prescribing a specific Schedule 4 product as the answer.
Practitioner-led content that explains your assessment philosophy without naming products.

What you cannot do:

Use treatment descriptors that point at specific Schedule 4 products as marketing copy
Show before-and-afters that exist solely because of Schedule 4 products
Use price lists that imply a specific Schedule 4 product
Use Schedule 4 product brand names anywhere in public-facing content

What about consultation pages?

The AHPRA cosmetic procedure advertising guidelines allow free consultations to be advertised — but only if positioned as "general information sessions, and not used as a sales tactic or implied endorsement of a treatment". The framing matters. A "free anti-wrinkle consultation" with a "book now" button next to a price list is a sales offer, not an information session.

A specific audit you can run today

Open every treatment page on your website and ask, page by page:

Does the page name a Schedule 4 product brand? Search for: Botox, Dysport, Xeomin, Juvéderm, Restylane, Belotero, Teoxane, Sculptra, Profhilo, Radiesse. Remove all instances. Check page metadata, image alt-text, and hashtags.
Does the page use a descriptor that indirectly references a Schedule 4 product? Common ones: anti-wrinkle injections, anti-wrinkle treatment, lip flip, dermal fillers, lip fillers, cheek fillers, jawline fillers, tear trough fillers, bio-stimulators, skin boosters. Each of these requires either removal or rewording into compliant generic language.
Are the before-and-afters showing Schedule 4 outcomes? If yes, they need to either come down or be re-presented in a way that does not imply a specific Schedule 4 product produced the result.
Does the language imply a specific outcome only Schedule 4 products produce? "Smooth out fine lines", "fuller lips", "restore lost volume" — these phrasings often imply a Schedule 4 mechanism even without naming the product. Generic medical language about "facial assessment" or "consultation outcomes" is safer.
Does the URL itself reference a Schedule 4 product or descriptor? A URL like /anti-wrinkle-injections-brisbane/ is itself indexed and discoverable. It needs to change — with a 301 redirect to the new compliant URL — or come down entirely.
Does your social media match? AHPRA has confirmed the same advertising rules apply on social media. Audit Instagram, Facebook, TikTok, and any influencer collaborations using the same checklist.

What this looks like in practice

A compliant cosmetic clinic homepage in 2026 might look like this:

Clinic name, location, hours
Practitioner profiles (registration, qualifications, scope of practice)
Generic information about the consultation process
Educational articles about cosmetic medicine concepts (ageing, facial assessment, treatment categories at a high level)
Contact and booking
A clear distinction between general information and clinical advice

What it does not contain:

A treatment menu listing specific procedures with implied Schedule 4 outcomes
Brand names or descriptors that map to specific Schedule 4 products
Patient testimonials about clinical services
Before-and-after pairs that depict Schedule 4 outcomes
Pricing tied to specific descriptors that imply Schedule 4 products
Inducements, packages, or limited-time offers

This is a significant shift from how most cosmetic clinic websites are currently structured. It requires a content rebuild, not a paint job.

How to handle the inevitable patient question

Patients searching for cosmetic services in 2026 will still type "anti-wrinkle injections near me" into Google. The shift is that you cannot present yourself in those search results using the same language. Compliant clinics are building their content around:

Practitioner-led explanations of cosmetic medicine principles
Consultation-focused messaging ("come in and we'll assess what's clinically appropriate")
High-quality educational content that doesn't double as a product advertisement
Strong organic search positioning around concepts (facial ageing, consultation, registered practitioner) rather than products

The clinics that are growing in 2026 are the ones that have rebuilt their websites for the new rules — not the ones still trying to find creative ways around them.

Frequently asked questions

Can we say "we offer injectable treatments" without naming the product?

Possibly, depending on context. The phrasing alone is more generic than "anti-wrinkle injections", but if the page uses imagery, before-and-afters, or surrounding copy that implies a specific Schedule 4 product, the indirect reference rule may still apply. The safest test is whether someone reading the page would conclude that you are offering a specific Schedule 4 product.

What if our patients ask about specific brand names?

There is no rule against discussing specific products in a private consultation between a patient and a registered practitioner. That is clinical care, not advertising. The prohibition is on advertising to the public. Once the conversation is one-on-one and clinical, normal informed-consent rules apply.

Are educational articles about cosmetic medicine still allowed?

Yes — and this is one of the better ways to communicate expertise without breaching the rules. Articles can discuss conditions, ageing, treatment categories at a high level, the consultation process, and the evidence base. They cannot become disguised product advertisements. The test is the same as elsewhere: does the article promote a specific Schedule 4 product or imply specific Schedule 4 outcomes?

Does this also apply to medical devices?

Different rules apply to medical devices, depending on classification. Some cosmetic medical devices are not Schedule 4 and follow different advertising rules. Always check the classification of any product or device before assuming it can be advertised. The TGA's ARTG database is the authority.

Who is liable if a breach is found — the practitioner or the clinic?

Both can be subject to action. AHPRA can take action against a registered practitioner. The TGA can take action against the business advertising the products. The 2026 prosecution under the National Law showed that businesses supporting clinical practice are also directly subject to enforcement. Liability is layered, not singular.